CNS pipeline · person

Andrew Ratz, PhD

Chief Technical Operations Officer of Neurocrine Biosciences since February 2026, responsible for global technical development, manufacturing, and supply chain as the company expands beyond small molecules into biologics and device-based therapies. He spent nearly 30 years at Eli Lilly, most recently as Senior Vice President, Delivery, Device and Connected Solutions.

  • 1 company

Courtesy Neurocrine Biosciences

Current roles

Appears with

People sharing a company with Andrew.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.